Skip to content
Open access · OA via OpenAlex

Telomere Length and Risk of Incident Cancer and Cancer Mortality

Peter Willeit, Johann Willeit, Agnes Mayr, Siegfried Weger, Friedrich Oberhollenzer, Anita Kloss‐Brandstätter, Florian Kronenberg, Stefan Kiechl

JAMA · 2010 · ▲ 484 citations

Abstract

CONTEXT: Telomeres are essential to preserve the integrity of the genome. Critically short telomeres lead to replicative cell senescence(definition) and chromosomal instability and may thereby increase cancer risk. OBJECTIVE: To determine the association between baseline telomere(definition) length and incident cancer and cancer mortality. DESIGN, SETTING, AND PARTICIPANTS: Leukocyte telomere length was measured by quantitative polymerase chain reaction in 787 participants free of cancer at baseline in 1995 from the prospective, population-based Bruneck Study in Italy. MAIN OUTCOME MEASURES: Incident cancer and cancer mortality over a follow-up period of 10 years (1995-2005 with a follow-up rate of 100%). RESULTS: A total of 92 of 787 participants (11.7%) developed cancer (incidence rate, 13.3 per 1000 person-years). Short telomere length at baseline was associated with incident cancer independently of standard cancer risk factors (multivariable hazard ratio [HR] per 1-SD decrease in log(e)-transformed telomere length, 1.60; 95% confidence interval [CI], 1.30-1.98; P < .001). Compared with participants in the longest telomere length group, the multivariable HR for incident cancer was 2.15 (95% CI, 1.12-4.14) in the middle length group and 3.11 (95% CI, 1.65-5.84) in the shortest length group (P < .001). Incidence rates were 5.1 (95% CI, 2.9-8.7) per 1000 person-years in the longest telomere length group, 14.2 (95% CI, 10.0-20.1) per 1000 person-years in the middle length group, and 22.5 (95% CI, 16.9-29.9) per 1000 person-years in the shortest length group. The association equally applied to men and women and emerged as robust under a variety of circumstances. Furthermore, short telomere length was associated with cancer mortality (multivariable HR per 1-SD decrease in log(e)-transformed telomere length, 2.13; 95% CI, 1.58-2.86; P < .001) and individual cancer subtypes with a high fatality rate. CONCLUSION: In this study population, there was a statistically significant inverse relationship between telomere length and both cancer incidence and mortality.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1001/jama.2010.897
Canonical
link ↗
Fetched
2026-06-02 MST

Cite this

APA
Willeit, P., Willeit, J., Mayr, A., Weger, S., Oberhollenzer, F., Kloss‐Brandstätter, A., Kronenberg, F., &amp; Kiechl, S. (2010). Telomere Length and Risk of Incident Cancer and Cancer Mortality. <em>JAMA</em>. https://doi.org/10.1001/jama.2010.897
Vancouver
Willeit P, Willeit J, Mayr A, Weger S, Oberhollenzer F, Kloss‐Brandstätter A, et al. Telomere Length and Risk of Incident Cancer and Cancer Mortality. JAMA. 2010. doi:10.1001/jama.2010.897.
BibTeX
@article{peter2010Telome, title = {Telomere Length and Risk of Incident Cancer and Cancer Mortality}, author = {Peter Willeit and Johann Willeit and Agnes Mayr and Siegfried Weger and Friedrich Oberhollenzer and Anita Kloss‐Brandstätter and Florian Kronenberg and Stefan Kiechl}, journal = {JAMA}, year = {2010}, doi = {10.1001/jama.2010.897}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings